Gelidium elegans, an edible red seaweed, and hesperidin inhibit lipid accumulation and production of reactive oxygen species and reactive nitrogen species in 3T3-L1 and RAW264.7 cells

Phytotherapy Research

Volumn 28, Issue 11, 2014, Pages 1701-1709

  Jeon, Hui Jeon ^a   Seo, Min Jung ^a   Choi, Hyeon Son ^a   Lee, Ok Hwan ^b   Lee, Boo Yong ^a  

^a CHA University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

3T3 L1; Gelidium elegans; Hesperin; Lipid accumulation; ROS production; Rutin

Indexed keywords

ALCOHOL; ALGAL EXTRACT; ANTIOBESITY AGENT; ANTIOXIDANT; CCAAT ENHANCER BINDING PROTEIN ALPHA; COPPER ZINC SUPEROXIDE DISMUTASE; FATTY ACID BINDING PROTEIN 4; GELIDIUM ELEGANS EXTRACT; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HESPERIDIN; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RUTOSIDE; UNCLASSIFIED DRUG; PLANT EXTRACT; SUPEROXIDE DISMUTASE;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG IDENTIFICATION; GELIDIUM ELEGANS; LIPID STORAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RED ALGA; SEAWEED; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; LIPID METABOLISM; MACROPHAGE; METABOLISM;

GELIDIUM ELEGANS; RHODOPHYTA;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIOXIDANTS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HESPERIDIN; LIPID METABOLISM; MACROPHAGES; MICE; NITRIC OXIDE; PLANT EXTRACTS; PPAR GAMMA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RHODOPHYTA; RUTIN; SEAWEED; SUPEROXIDE DISMUTASE;

EID: 84918797244     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5186     Document Type: Article

References (48)

1. Adachi T, Toishi T. 2009. Expression of extracellular superoxide dismutase during adipose differentiation in 3T3-L1 cells. Redox Rep 14: 34-40.
2. Al-Ashaal HA, El-Sheltawy ST. 2011. Antioxidant capacity of hesperidin from citrus peel using electron spin resonance and cytotoxic activity against human carcinoma cell lines. Pharm Biol 49: 276-282.
3. Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A. 2009. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 89: 27-71.
4. Chen M, Gu H, Ye Y, et al. 2010. Protective effects of hesperidin against oxidative stress of tert-butyl hydroperoxide in human hepatocytes. Food Chem Toxicol 48: 2980-2987.
5. Chiba H, Uehara M, Wu J, et al. 2003. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133: 1892-1897.
6. Choi IW, Park YK, Choi HD, Lee EJ. 2006. Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with high-fat diet. Biofactors 26: 273-281.
7. Chojnacka K, Saeid A, Witkowska Z, Tuhy L. 2012. Biologically active compounds in seaweed extracts - the prospects for the application. Open Conf Proc J 3: 20-28.
8. Furukawa S, Fujita T. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Investig 114: 1752-1761.
9. Galati EM, Monforte MT, Kirjavainen S, Forestieri AM, Trovato A, Tripodo MM. 1994. Biological effects of hesperidin, a citrus flavonoid. Note I: antiinflammatory and analgesic activity. Pharmacology 40: 709-712.
10. Gupta S, Abu-Ghannam N. 2011a. Recent developments in the application of seaweeds or seaweed extracts as a means for enhancing the safety and quality attributes of foods. Innovat Food Sci Emerg Tech 12: 600-609.
11. Gupta S, Abu-Ghannam N. 2011b. Bioactive potential and possible health effects of edible brown seaweeds. Trends Food Sci Tech 22: 315-326.
12. Hertzog MG, Kromhout D, Aravanis C, et al. 1995. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386.
13. Hsu CL, Yen GC. 2007. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J Agric Food Chem 55: 8404-8410.
14. Hung HC, Joshipura KJ, Jiang R, et al. 2004. Fruit and vegetable intake and risk of major chronic disease. J Natl Canc Inst 96: 1557-1584.
15. Ikemura M, Sasaki Y, Giddings JC, Yamato J. 2012. Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res 26: 1272-1277.
16. Jeon HJ, Choi HS, Lee OK, Jeon YJ, Lee BY. 2012. Inhibition of reactive oxygen species (ROS) and nitric oxide (NO) by Gelidium elegnags using alternative drying and extraction conditions in 3T3-L2 and RAW264.7 cells. Prev Nutr Food Sci 17: 122-128.
17. Jung UJ, Lee MK, Park YB, Kang MA, Choi MS. 2006. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 38: 1134-1145.
18. Kang SI, Ko HC, Shin HS, et al. 2011. Fucoxanthin exerts differing effects on 3T3-L1 cells according to differentiation stage and inhibits glucose uptake in mature adipocytes. Biochem Biophy Res Comm 409: 769-774.
19. Kazowska K, Hsu T, Hou CC, Yang WC, Tsai GJ. 2010. Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentate. J Ethnopharmacol 128: 123-130.
20. Kaul TN, Middleton E, Jr., Ogra PL. 1985. Antiviral effect of flavonoids on human viruses. J Med Virol 15: 71-79.
21. Keyrouz R, Abasq ML, Le Bourvellec C. 2011. Total phenolic contents, radical scavenging and cyclic voltammetry of seaweeds from Brittany. Food Chem 126: 831-836.
22. Kim GS, Park HJ,Woo JH, et al. 2012. Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. BMC Compl Alternative Med 3: 12-31.
23. Kim KJ, Lee OH, Lee BY. 2010. Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci 22: 791-797.
24. Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 312: 478-481.
25. Kuznetsova TA, Besednova NN, Mamaev AN, Momot AP, Shevchenko NM, Zvyagintseva TN. 2003. Anticoagulant activity of fucoidan from brown algae Fucus evanescens of the Okhotsk Sea. Bull Exp Biol Med 5: 471-473.
26. Lee OH, Kwon YI, Apostolidis E, Shetty K, Kim YC. 2011. Rhodiolainduced inhibition of adipogenesis involves antioxidant enzyme response associated with pentose phosphate pathway. Phytother Res 25: 106-115.
27. Maeda H, Hosokawa M, Sashima T, Takahashi N, Kawada T, Miyashita K. 2006. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int J Mol Med 18: 147-152.
28. McCord JM, Fridovich I. 1988. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med 5: 363-369.
29. Middleton EJ. 1998. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 439: 175-182.
30. Moller DE, Flier JS. 1991. Insulin resistance-mechanisms, syndromes, and implications. New Engl J Med 325: 938-948.
31. Moon PD, Kim HM. 2012. Anti-inflammatory effects of traditional Korean medicine, JinPi-tang and its active ingredient, hesperidin in HaCaT cells. Phytother Res 26: 657-662.
32. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425.
33. Ohtsuki K, Abe A, Mitsuzumi H, et al. 2003. Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature. J Nutr Sci Vitaminol 49: 447-450.
34. Pangestuti R, Kim SK. 2011. Biological activities and health benefit effects of natural pigments derived from marine algae. J Funct Foods 3: 255-266.
35. Pearson SL, Cawthorne MA, Clapharm JC. 1996. The thiazolidinedione insulin sensitizer, BRL49653, increase the expression of PPAR and aP2 in adipose tissue of high fat fed rats. Biochem Biophys Res Comm 229: 752-757.
36. Romano B, Pagano E, Montanaro V, Fortunato AL, Milic N, Borrelli F. 2013. Novel insights into the pharmacology of flavonoids. Phytother Res 17: 1588-1596.
37. Sarojini Y, Lakshminarayana K, Seshagiri Rao P. 2012. Variations in distribution of flavonoids in some seaweed of Visakhapatnam coast of India. Der Pharm Chem 4: 481-484.
38. Sathishkumar T, Baskar R, Shanmugam S, Rajasekaran P, Sadasivam S, Manikandan V. 2008. Optimization of flavonoids extraction from the leaves of Tabernaemontana heyneana Wall. using L16 orthogonal design. Nat Sci 6: 10-21.
39. Scherer PE. 2006. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55: 1537-1545.
40. Seo MJ, Choi HS, Lee OK, Lee BY. 2012. Grateloupia lanceolata (Okamura) Kawaguchi, the edible red seaweed, inhibits lipid accumulation and reactive oxygen species production during differentiation in 3T3-L1 cells. Phytother Res 27: 655-663.
41. Souza BW, Cerqueira MA, Martins JT, et al. 2011. Antioxidant potential of two red seaweeds from the Brazilian coasts. J Agric Food Chem 59: 5589-5594.
42. Stefani ED, Boffetta P, Deneo-Pellegrini H, et al. 1999. Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34: 100-110.
43. Stein JR, Borden CA. 1984. Causative and beneficial algae in human disease conditions. Phycologia 23: 485-501.
44. Swanson AK, Druehl LD. 2002. Induction, exudation and the UV protective role of kelp phlorotannins. Aquatic Bot 73: 241-253.
45. Takamatsu S, Hodges TW, Rajbhandari I, Gerwick WH, Hamann MT, Nagle DG. 2003. Marine natural products as novel antioxidant prototypes. J Nat Prod 66: 605-608.
46. Thomas D. 2002. Seaweeds. The Natural History Museum: London, 15.
47. Wasowski C, Loscalzo LM, Higgs J, Marder M. 2012. Chronic interperitoneal and oral treatments with hesperidin induce central nervous system effects in mice. Phytother Res 26: 308-312.
48. Yoshie-Stark Y, Hsieh YP, Suzuki T. 2003. Distribution of flavonoids and related compounds from seaweeds in Japan. J Tokyo Univ Fish 89: 1-6.